-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Acupuncture with Planning Treatment According to Diagnosis: A Trial Study of Protocol and its Effects for Stiff Shoulder
Wenping Zhang, Atushi Takeda, Kaito Mizuno, Masayuki Kanehara, Ken Takagi, Ryohei Ishiyama, Shigeru Urata, Ko Nishimura
Commentary: Clinical Investigation
-
Acupuncture with Planning Treatment According to Diagnosis: A Trial Study of Protocol and its Effects for Stiff Shoulder
Wenping Zhang, Atushi Takeda, Kaito Mizuno, Masayuki Kanehara, Ken Takagi, Ryohei Ishiyama, Shigeru Urata, Ko Nishimura
Commentary: Clinical Investigation
-
Acupuncture with Planning Treatment According to Diagnosis: A Trial Study of Protocol and its Effects for Stiff Shoulder
Wenping Zhang, Atushi Takeda, Kaito Mizuno, Masayuki Kanehara, Ken Takagi, Ryohei Ishiyama, Shigeru Urata, Ko Nishimura
Commentary: Clinical Investigation
-
Acupuncture with Planning Treatment According to Diagnosis: A Trial Study of Protocol and its Effects for Stiff Shoulder
Wenping Zhang, Atushi Takeda, Kaito Mizuno, Masayuki Kanehara, Ken Takagi, Ryohei Ishiyama, Shigeru Urata, Ko Nishimura
Commentary: Clinical Investigation
-
Acupuncture with Planning Treatment According to Diagnosis: A Trial Study of Protocol and its Effects for Stiff Shoulder
Wenping Zhang, Atushi Takeda, Kaito Mizuno, Masayuki Kanehara, Ken Takagi, Ryohei Ishiyama, Shigeru Urata, Ko Nishimura
Commentary: Clinical Investigation
-
Acupuncture with Planning Treatment According to Diagnosis: A Trial Study of Protocol and its Effects for Stiff Shoulder
Wenping Zhang, Atushi Takeda, Kaito Mizuno, Masayuki Kanehara, Ken Takagi, Ryohei Ishiyama, Shigeru Urata, Ko Nishimura
Commentary: Clinical Investigation
-
Acupuncture with Planning Treatment According to Diagnosis: A Trial Study of Protocol and its Effects for Stiff Shoulder
Wenping Zhang, Atushi Takeda, Kaito Mizuno, Masayuki Kanehara, Ken Takagi, Ryohei Ishiyama, Shigeru Urata, Ko Nishimura
Commentary: Clinical Investigation
-
Acupuncture with Planning Treatment According to Diagnosis: A Trial Study of Protocol and its Effects for Stiff Shoulder
Wenping Zhang, Atushi Takeda, Kaito Mizuno, Masayuki Kanehara, Ken Takagi, Ryohei Ishiyama, Shigeru Urata, Ko Nishimura
Commentary: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation